Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yupingfengguizhi solution is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Yunnan Traditional Chinese Medicine Hospital. It is a combination of two classic TCM prescriptions: Yupingfeng San (Jade Windscreen Powder) and Guizhi Tang (Cinnamon Twig Decoction). The solution is primarily investigated for its role in treating rheumatoid arthritis, specifically as an adjunctive therapy to facilitate the tapering of glucocorticoids. It is thought to work by balancing the immune system and reducing the inflammatory response, thereby preventing disease flares during steroid reduction. The formulation typically includes herbs such as *Astragalus membranaceus*, *Atractylodes macrocephala*, *Saposhnikovia divaricata*, *Cinnamomum cassia*, and *Paeonia lactiflora*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yupingfengguizhi solution.